ATE452649T1 - Rgd-angereicherte, gelatine-ähnliche proteine zur verhinderung der zelladhäsion - Google Patents

Rgd-angereicherte, gelatine-ähnliche proteine zur verhinderung der zelladhäsion

Info

Publication number
ATE452649T1
ATE452649T1 AT07111368T AT07111368T ATE452649T1 AT E452649 T1 ATE452649 T1 AT E452649T1 AT 07111368 T AT07111368 T AT 07111368T AT 07111368 T AT07111368 T AT 07111368T AT E452649 T1 ATE452649 T1 AT E452649T1
Authority
AT
Austria
Prior art keywords
rgd
enriched
gelatine
amino acids
gelatines
Prior art date
Application number
AT07111368T
Other languages
English (en)
Inventor
Jan Bastiaan Bouwstra
Es Andries Johannes Jozef Van
Yuzo Toda
Original Assignee
Fuji Film Mfg Europ B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Film Mfg Europ B V filed Critical Fuji Film Mfg Europ B V
Application granted granted Critical
Publication of ATE452649T1 publication Critical patent/ATE452649T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/222—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/045—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C12N5/0075—General culture methods using substrates using microcarriers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
AT07111368T 2003-03-28 2004-03-26 Rgd-angereicherte, gelatine-ähnliche proteine zur verhinderung der zelladhäsion ATE452649T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03075906 2003-03-28

Publications (1)

Publication Number Publication Date
ATE452649T1 true ATE452649T1 (de) 2010-01-15

Family

ID=33041011

Family Applications (4)

Application Number Title Priority Date Filing Date
AT07111303T ATE450548T1 (de) 2003-03-28 2004-03-26 Rgd-angereicherte gelatineähnliche proteine mit verstärkter zellbindung
AT07111368T ATE452649T1 (de) 2003-03-28 2004-03-26 Rgd-angereicherte, gelatine-ähnliche proteine zur verhinderung der zelladhäsion
AT07111329T ATE465747T1 (de) 2003-03-28 2004-03-26 Rgd-angereicherte gelatineähnliche proteine zur verhinderung der blutplättchenaggregation
AT04723872T ATE397626T1 (de) 2003-03-28 2004-03-26 Rgd-angereicherte gelatine-ähnliche proteine mit verstärkter zellbindung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT07111303T ATE450548T1 (de) 2003-03-28 2004-03-26 Rgd-angereicherte gelatineähnliche proteine mit verstärkter zellbindung

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT07111329T ATE465747T1 (de) 2003-03-28 2004-03-26 Rgd-angereicherte gelatineähnliche proteine zur verhinderung der blutplättchenaggregation
AT04723872T ATE397626T1 (de) 2003-03-28 2004-03-26 Rgd-angereicherte gelatine-ähnliche proteine mit verstärkter zellbindung

Country Status (6)

Country Link
US (8) US7517954B2 (de)
EP (7) EP1862476B1 (de)
JP (6) JP4834540B2 (de)
AT (4) ATE450548T1 (de)
DE (4) DE602004026944D1 (de)
WO (1) WO2004085473A2 (de)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004026944D1 (de) * 2003-03-28 2010-06-10 Fujifilm Mfg Europe Bv RGD-angereicherte gelatineähnliche Proteine zur Verhinderung der Blutplättchenaggregation
US8227415B2 (en) 2005-04-06 2012-07-24 Fujifilm Manufacturing Europe B.V. Non-porous film for culturing cells
WO2006107188A1 (en) 2005-04-06 2006-10-12 Fujifilm Manufacturing Europe B.V. A non-porous film for culturing cells
US8980323B2 (en) 2006-08-29 2015-03-17 Fujifilm Corporation Hydrophilic matrix containing poorly water-soluble compound and method for producing the same
EP1961411A1 (de) 2007-02-21 2008-08-27 FUJIFILM Manufacturing Europe B.V. Zusammensetzung mit gesteuerter Freisetzung
EP1961414A1 (de) * 2007-02-21 2008-08-27 FUJIFILM Manufacturing Europe B.V. Rekombinante Gelatine enthaltende Zusammensetzung mit gesteuerter Freisetzung
ATE551364T1 (de) * 2007-02-21 2012-04-15 Fujifilm Mfg Europe Bv Nicht natürliche rekombinante gelatinen mit erweiterter funktionalität
WO2008133196A1 (ja) * 2007-04-19 2008-11-06 Fujifilm Corporation 再生医療用材料
JP2008266179A (ja) 2007-04-19 2008-11-06 Fujifilm Corp 経肺用組成物
JP2009051773A (ja) * 2007-08-27 2009-03-12 Toyobo Co Ltd 細胞接着能を有するｈｓｐ７０ファミリータンパク質
WO2009069727A1 (ja) 2007-11-28 2009-06-04 Fujifilm Corporation 生体高分子およびポリペプチドの化学修飾方法
GB0724179D0 (en) * 2007-12-11 2008-01-23 Ct For Process Innovation The Fermentation process
WO2009075329A1 (ja) * 2007-12-11 2009-06-18 Fujifilm Corporation 分解性を調整したゼラチン組成物
US20110106243A1 (en) * 2008-07-04 2011-05-05 Elisabeth Marianna Wilhelmina Maria Van Dongen Coating Method for Medical Devices
JP2010053080A (ja) 2008-08-28 2010-03-11 Fujifilm Corp キトサンとコラーゲンを含む構造体
FR2936247B1 (fr) * 2008-09-24 2010-10-22 Ct Hospitalier Universitaire De Dijon Proteines recombinantes a activite hemostatique capables d'induire l'agregation plaquettaire.
US8263133B2 (en) * 2009-02-18 2012-09-11 The Regents Of The University Of California Multivalent clustering targeting strategy for drug carriers
EP2428215B1 (de) * 2009-05-07 2017-10-18 FUJIFILM Corporation Rekombinante Gelatine zur Verwendung in der Behandlung von ischämischen und Herzerkrankungen und anderen
US8877158B2 (en) * 2009-06-12 2014-11-04 Fujifilm Corporation Targeting agent to newly formed blood vessels
WO2010147109A1 (ja) * 2009-06-15 2010-12-23 富士フイルム株式会社 遺伝子組み換えゼラチン及び塩基性線維芽細胞増殖因子を含む血管新生誘導剤
EP2460541B1 (de) 2009-07-30 2018-01-17 FUJIFILM Corporation Nierenbildgebungsmittel enthaltend rekombinante gelatine
WO2011013791A1 (ja) 2009-07-30 2011-02-03 富士フイルム株式会社 遺伝子組み換えゼラチンを含む腎臓標的ドラッグデリバリー剤
EP2478923B1 (de) 2009-09-04 2016-05-04 FUJIFILM Corporation Ein knochenregenerierungsmittel, das gelatine umfasst
GB0921460D0 (en) 2009-12-08 2010-01-20 Fujifilm Mfg Europe Bv Anti-fibrotic hydrogel compositions
US8961929B2 (en) 2010-01-08 2015-02-24 Fujifilm Corporation Targeting agent for tumor site
KR101744040B1 (ko) 2010-03-01 2017-06-07 후지필름 가부시키가이샤 생체 친화성을 갖는 고분자 블록과 세포로 이루어지는 세포 구조체
JP5889780B2 (ja) 2010-03-02 2016-03-22 富士フイルム株式会社 細胞支持体及び骨再生材
GB201008404D0 (en) 2010-05-20 2010-07-07 Fujifilm Mfg Europe Bv Hemostatic compositions
GB201014388D0 (en) 2010-08-31 2010-10-13 Fujifilm Mfg Europe Bv Biocompatible compositions for tissue augmentation
GB201018044D0 (en) 2010-10-26 2010-12-08 Fujifilm Mfg Europe Bv Non-natural gelatin-like proteins with enhanced functionality
JP5847418B2 (ja) 2011-03-30 2016-01-20 富士フイルム株式会社 細胞接着性タンパク質
US20120263681A1 (en) 2011-04-12 2012-10-18 Fujifilm Corporation Composition comprising cell and biocompatible polymer
JP5876787B2 (ja) 2011-08-31 2016-03-02 富士フイルム株式会社 細胞移植用細胞構造体および細胞移植用細胞集合体
JP5808631B2 (ja) 2011-09-29 2015-11-10 富士フイルム株式会社 血管新生用足場、及び再生医療用の血管の製造方法
GB201119173D0 (en) 2011-11-07 2011-12-21 Fujifilm Mfg Europe Bv Porous tissue scaffolds
GB201119182D0 (en) 2011-11-07 2011-12-21 Fujifilm Mfg Europe Bv Porous tissue scaffolds
EP2826494B1 (de) 2012-03-12 2021-01-06 Fujifilm Corporation Verfahren zur herstellung von gewebereparaturmaterial
JP5992529B2 (ja) 2012-09-26 2016-09-14 富士フイルム株式会社 ポリペプチド、足場組成物、軟骨組織修復用組成物、軟骨細胞培養用組成物及びグリコサミノグリカン産生促進用組成物
JPWO2014115732A1 (ja) 2013-01-25 2017-01-26 富士フイルム株式会社 移植用人工真皮およびその製造方法
CN107033383B (zh) 2013-02-27 2020-07-24 富士胶片株式会社 制造生物亲和性高分子的多孔体的方法
WO2014141877A1 (ja) 2013-03-12 2014-09-18 富士フイルム株式会社 組織修復材
WO2015046216A1 (ja) 2013-09-25 2015-04-02 富士フイルム株式会社 生体親和性高分子多孔質体の製造方法、生体親和性高分子多孔質体、生体親和性高分子ブロック並びに細胞構造体
WO2015194494A1 (ja) 2014-06-16 2015-12-23 富士フイルム株式会社 脳損傷治療用細胞構造体、その製造方法、及び脳損傷治療剤
US11058749B2 (en) 2015-04-28 2021-07-13 Frank DiCosmo Bioactive collagen biomaterials and methods for making
WO2016208673A1 (ja) 2015-06-25 2016-12-29 学校法人早稲田大学 コラーゲン様構造を有する重合ペプチド及びゲル
WO2017043489A1 (ja) 2015-09-11 2017-03-16 富士フイルム株式会社 ゼラチン構造体製造方法、及びゼラチン構造体製造システム
JPWO2017170342A1 (ja) 2016-03-29 2019-01-17 富士フイルム株式会社 細胞シート包埋剤、細胞シート含有組成物およびキット
WO2017183710A1 (ja) 2016-04-21 2017-10-26 フジフィルム・マニュファクチュアリング・ヨーロッパ・ベスローテン・フエンノートシャップ 多孔質ゼラチンシートの製造方法、多孔質ゼラチンシートおよびその利用
EP3974403A1 (de) 2016-05-30 2022-03-30 FUJIFILM Corporation Verfahren zur herstellung eines kalziumphosphatformartikels, kalziumphosphatformartikel und material zur transplantation
JP6637598B2 (ja) 2016-06-08 2020-01-29 富士フイルム株式会社 ゼラチン成形体の製造方法及びゼラチン成形体
JP6865265B2 (ja) 2017-03-02 2021-04-28 富士フイルム株式会社 細胞塊または細胞構造体の包埋剤、細胞塊または細胞構造体含有組成物およびキット
WO2018169061A1 (ja) 2017-03-16 2018-09-20 富士フイルム株式会社 巨核球と血小板とを分離する方法および巨核球と血小板とを分離するための器具
WO2018169065A1 (ja) 2017-03-17 2018-09-20 富士フイルム株式会社 細胞構造体の製造方法
JPWO2018207923A1 (ja) 2017-05-12 2020-03-12 富士フイルム株式会社 間葉系幹細胞の製造方法、およびその応用
CN110913920A (zh) 2017-06-30 2020-03-24 富士胶片株式会社 溶酶体贮积病处置剂
JP6854904B2 (ja) 2017-08-30 2021-04-07 富士フイルム株式会社 血管新生剤およびその製造方法
JP6941175B2 (ja) 2017-08-30 2021-09-29 富士フイルム株式会社 細胞移植用デバイスおよびその製造方法
KR102476632B1 (ko) * 2017-11-06 2022-12-09 후지필름 가부시키가이샤 진주 양식용 재료 및 코팅용 조성물
WO2019093468A1 (ja) 2017-11-10 2019-05-16 富士フイルム株式会社 間葉系幹細胞からインスリン産生細胞を製造する方法、インスリン産生細胞、細胞構造体および医薬組成物
EP3747475A4 (de) 2018-01-30 2021-06-02 FUJIFILM Corporation Fibrinzusammensetzung, basismaterial für die regenerative medizin, verfahren zur herstellung der fibrinzusammensetzung und kit
EP3848063A4 (de) 2018-09-03 2021-10-27 FUJIFILM Corporation Gelbildungskit, gel und verfahren zur herstellung von gel
KR102141537B1 (ko) 2019-03-11 2020-08-06 재단법인대구경북과학기술원 신경 줄기세포의 구형배양 방법
JP7385664B2 (ja) 2019-07-26 2023-11-22 富士フイルム株式会社 生体移植材料
WO2021039610A1 (ja) 2019-08-23 2021-03-04 富士フイルム株式会社 ミクロカプセルと細胞構造体とを含む組成物
JP7524319B2 (ja) 2020-05-25 2024-07-29 富士フイルム株式会社 組成物、シート状成形体、人工皮革およびシート状成形体の製造方法
JPWO2022202632A1 (de) 2021-03-24 2022-09-29
CN117043535A (zh) 2021-03-26 2023-11-10 富士胶片株式会社 冷冻干燥用容器
CN117062766A (zh) 2021-03-26 2023-11-14 富士胶片株式会社 粉体供给装置
CN117042884A (zh) 2021-03-31 2023-11-10 富士胶片株式会社 粉碎方法、高分子嵌段物制造方法及粉碎装置
JP7333121B2 (ja) 2021-08-02 2023-08-24 株式会社Rainbow 幹細胞を非凍結で保存または輸送するための方法
CN113788891B (zh) * 2021-09-15 2023-10-31 山西锦波生物医药股份有限公司 一种重组i型人源化胶原蛋白c1l4t及其制备方法和用途
WO2023053710A1 (ja) 2021-09-30 2023-04-06 富士フイルム株式会社 組織修復材キット及び組織修復方法
JPWO2023188492A1 (de) 2022-03-30 2023-10-05

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4988621A (en) * 1985-05-24 1991-01-29 La Jolla Cancer Research Foundation Peptides in cell detachment and aggregation
US5514581A (en) * 1986-11-04 1996-05-07 Protein Polymer Technologies, Inc. Functional recombinantly prepared synthetic protein polymer
CA1324954C (en) * 1988-03-10 1993-12-07 Erkki I. Ruoslahti Inhibition of cell migration with synthetic peptides
US4994388A (en) 1988-04-15 1991-02-19 Solohill Engineering, Inc. Collagen-coated polystyrene microcarrier beads
JPH04221400A (ja) * 1990-10-26 1992-08-11 Fuji Photo Film Co Ltd ゼラチン誘導体およびその用途
US5179082A (en) * 1990-11-13 1993-01-12 Merck & Co., Inc. Method for blocking platelet adhesion to collagen
ATE179074T1 (de) * 1991-11-07 1999-05-15 Univ Southern California Zusammensetzungen und verfahren zur verhinderung der adhäsionbildung
US5512474A (en) 1992-05-29 1996-04-30 Bsi Corporation Cell culture support containing a cell adhesion factor and a positively-charged molecule
JPH06192291A (ja) 1992-09-07 1994-07-12 Nippon Steel Corp 新規ペプチドとそれを用いた血小板凝集抑制剤及び血液凝固抑制剤
KR100186656B1 (ko) * 1993-09-30 1999-04-01 하루히고 오쿠무라 신규한 펩타이드, 및 전기 펩타이드를 이용하는 혈소판 응집저해제, 체외순환하는 혈액의 혈액응고 저해제, 세포점착저해제, 종양전이 저해제, 수혈용 혈소판 제제의 보호제, 수혈용 혈소판 제제 및 혈소판 제제 팩
IL114140A (en) * 1995-06-14 2000-06-01 Hadasit Med Res Service Anti-metastatic and anti-angiogenetic pharmaceutical compositions
CA2269801A1 (en) * 1996-10-29 1998-05-07 Commonwealth Scientific And Industrial Research Organisation Stable expression of triple helical proteins
US5972332A (en) 1997-04-16 1999-10-26 The Regents Of The University Of Michigan Wound treatment with keratinocytes on a solid support enclosed in a porous material
NL1007908C2 (nl) 1997-12-24 1999-06-25 Fuji Photo Film Bv Zilverhalide-emulsies met recombinant collageen die geschikt zijn voor fotografische toediening alsmede de bereiding daarvan.
EP1014176B1 (de) 1998-12-23 2009-04-29 FUJIFILM Manufacturing Europe B.V. Silberhalogenidemulsionen, die rekombinante gelatineartige Proteine enthalten
US6992172B1 (en) * 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
RU2002112751A (ru) * 1999-11-12 2004-02-27 Файброджен, Инк. (Us) Рекомбинантные желатины
AU2001249079B2 (en) * 2000-02-28 2005-11-03 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
AUPR311601A0 (en) * 2001-02-15 2001-03-08 Adp Pharmaceutical Pty Limited Matrix gene expression in chondrogenesis
EP1238675A1 (de) 2001-03-06 2002-09-11 Fuji Photo Film B.V. Rekombinante gelatineartige Proteine zur Verwendung als Plasmaexpander
DE602004026944D1 (de) * 2003-03-28 2010-06-10 Fujifilm Mfg Europe Bv RGD-angereicherte gelatineähnliche Proteine zur Verhinderung der Blutplättchenaggregation
WO2013004646A1 (en) 2011-07-05 2013-01-10 Unilever N.V. Laminate for packaging

Also Published As

Publication number Publication date
US7671016B2 (en) 2010-03-02
US20090182063A1 (en) 2009-07-16
US20100222264A1 (en) 2010-09-02
EP1608681A2 (de) 2005-12-28
EP1875924A3 (de) 2008-02-13
ATE465747T1 (de) 2010-05-15
EP1608681B1 (de) 2008-06-04
JP4834618B2 (ja) 2011-12-14
US20060241032A1 (en) 2006-10-26
EP1894945A3 (de) 2008-10-29
EP1875924A2 (de) 2008-01-09
US20080113910A1 (en) 2008-05-15
EP1845107A2 (de) 2007-10-17
WO2004085473A2 (en) 2004-10-07
JP2007297402A (ja) 2007-11-15
EP1875924B1 (de) 2010-04-28
EP2112163A3 (de) 2010-01-20
EP1862476B1 (de) 2009-12-23
US8138139B2 (en) 2012-03-20
EP2112163A2 (de) 2009-10-28
US7560427B2 (en) 2009-07-14
WO2004085473A3 (en) 2005-04-21
DE602004024463D1 (de) 2010-01-14
EP1862476A3 (de) 2008-02-13
US20080167446A1 (en) 2008-07-10
US8080515B2 (en) 2011-12-20
EP1845107A3 (de) 2008-01-23
DE602004024834D1 (de) 2010-02-04
JP2007314545A (ja) 2007-12-06
JP2007297401A (ja) 2007-11-15
EP1845107B1 (de) 2019-05-29
EP1894945A2 (de) 2008-03-05
US7598347B2 (en) 2009-10-06
US20080274957A1 (en) 2008-11-06
ATE450548T1 (de) 2009-12-15
JP2007528699A (ja) 2007-10-18
ATE397626T1 (de) 2008-06-15
US20080114078A1 (en) 2008-05-15
EP1862476A2 (de) 2007-12-05
DE602004014263D1 (de) 2008-07-17
JP4834540B2 (ja) 2011-12-14
US7517954B2 (en) 2009-04-14
US7579314B2 (en) 2009-08-25
DE602004026944D1 (de) 2010-06-10
JP2007308507A (ja) 2007-11-29
US20100048477A1 (en) 2010-02-25
JP2007297403A (ja) 2007-11-15
EP1918301A1 (de) 2008-05-07
US7645737B2 (en) 2010-01-12
EP1894945B1 (de) 2009-12-02

Similar Documents

Publication Publication Date Title
ATE452649T1 (de) Rgd-angereicherte, gelatine-ähnliche proteine zur verhinderung der zelladhäsion
Tachibana et al. Fabrication of wool keratin sponge scaffolds for long-term cell cultivation
EP0366777B1 (de) Erregung der chemotaxe durch chemotaktische peptide
Ramshaw et al. Collagens as biomaterials
Bat et al. Biodegradable elastomers for biomedical applications and regenerative medicine
Przybyla et al. Higher-order assembly of collagen peptides into nano-and microscale materials
US5519004A (en) Elastomeric polypeptide matrices for preventing adhesion of biological materials
Sreejalekshmi et al. Biomimeticity in tissue engineering scaffolds through synthetic peptide modifications—altering chemistry for enhanced biological response
US20060178743A1 (en) Synovial fluid barrier
US20160194378A1 (en) Peptides and uses thereof
Yeo et al. The elastin matrix in tissue engineering and regeneration
WO2004076631A3 (en) Biologically active native biomatrix composition
DK1437969T3 (da) Instrumenter til autolog transplantation
WO2006047315A3 (en) Targeted delivery of biological factors using self-assembling peptide nanofibers
US4693718A (en) Stimulation of chemotaxis by chemotactic peptides
US20130230573A1 (en) Collagen structures and method of fabricating the same
CN111936560A (zh) 用于刺激神经再生、骨生成和血管生成的水凝胶
Hanson et al. Mechanical characterization and in vitro chondrogenic evaluation of chemically crosslinked elastin-like polypeptide hydrogels
ATE260681T1 (de) Partikuläres konstrukt zur verwendung in der transplantationsmedizin
Rocha et al. Unraveling the Potential of Chondrosia reniformis Collagen for Tissue Engineering Scaffolds, with Particular Insights into Chondrogenic Differentiation
Grassi et al. 5 Fibrillar Fibrin Gels
Conconi et al. Vascular cell response to human elastin-like polypeptide-based matrices and coatings
Dahl The impact of collagen on the mechanical properties of engineered arteries
Anderson The effect of mechanical force on collagen phenotype synthesis of periodontal tissues in vitro
TAKEI Self-assembling 3-dimensional scaffold peptide hydrogel for bone and general tissue regeneration

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties